Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pediatric Trials Network Long-term Antipsychotic Pediatric Safety Trial (LAPS) NICHD-2016-LAP01 Phase 4 Trial

NCT03522168 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03522168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03522168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pediatric Trials Network Long-term Antipsychotic Pediatric Safety Trial (LAPS) NICHD-2016-LAP01 Phase 4 Trial
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
January 10, 2019
Completion date
November 21, 2023
Enrollment
509 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

weight, body